Cargando…

Real‐World Nonmotor Changes in Patients with Parkinson's Disease and Motor Fluctuations: J‐FIRST

BACKGROUND: Nonmotor symptoms (NMSs) of Parkinson's disease (PD) impair health‐related quality of life. OBJECTIVES: To identify changes in NMSs during 52 weeks in Japanese PD patients exhibiting motor fluctuations. METHODS: In PD patients with ≥1 NMS and wearing‐off, changes in total/subscore o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Watanabe, Hirohisa, Saiki, Hidemoto, Chiu, Shih‐Wei, Yamaguchi, Takuhiro, Kashihara, Kenichi, Tsuboi, Yoshio, Nomoto, Masahiro, Hattori, Nobutaka, Maeda, Tetsuya, Shimo, Yasushi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2020
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7197319/ https://www.ncbi.nlm.nih.gov/pubmed/32373660 http://dx.doi.org/10.1002/mdc3.12939

Ejemplares similares

Nonmotor Symptoms in Patients with PARK2 Mutations
por: Yoritaka, Asako, et al.
Publicado: (2011)

Randomized, Controlled Study of Opicapone in Japanese Parkinson's Patients with Motor Fluctuations
por: Takeda, Atsushi, et al.
Publicado: (2020)

Motor/Nonmotor Symptoms and Progression in Patients with Parkinson's Disease: Prevalence and Risks in a Longitudinal Study
por: Yoritaka, Asako, et al.
Publicado: (2020)

Long-term safety and efficacy of opicapone in Japanese Parkinson’s patients with motor fluctuations
por: Takeda, Atsushi, et al.
Publicado: (2021)

Collective Expert Perspectives on the Use of Safinamide as Adjunctive Therapy for Parkinson's Disease: Online-Based Delphi Survey
por: Takeda, Atsushi, et al.
Publicado: (2022)

Correction: Long-term effects of safinamide adjunct therapy on levodopa-induced dyskinesia in Parkinson’s disease: post-hoc analysis of a Japanese phase III study
por: Hattori, Nobutaka, et al.
Publicado: (2022)

Long-term effects of safinamide adjunct therapy on levodopa-induced dyskinesia in Parkinson’s disease: post-hoc analysis of a Japanese phase III study
por: Hattori, Nobutaka, et al.
Publicado: (2022)

A randomized double-blind multi-center trial of hydrogen water for Parkinson’s disease: protocol and baseline characteristics
por: Yoritaka, Asako, et al.
Publicado: (2016)

Erratum to: A randomized double-blind multi-center trial of hydrogen water for Parkinson’s disease: protocol and baseline characteristics
por: Yoritaka, Asako, et al.
Publicado: (2017)

The Effects of Safinamide Adjunct Therapy on Depression and Apathy in Patients With Parkinson's Disease: Post-hoc Analysis of a Japanese Phase 2/3 Study
por: Hattori, Nobutaka, et al.
Publicado: (2022)

Intrajejunal Infusion of Levodopa/Carbidopa for Advanced Parkinson's Disease: A Systematic Review
por: Tsunemi, Taiji, et al.
Publicado: (2021)

Nonmotor Symptoms of Parkinson's Disease
por: Rektorova, Irena, et al.
Publicado: (2011)

Nonmotor Symptoms of Parkinson's Disease
por: Wu, Shey-Lin, et al.
Publicado: (2017)

Intestinal Collinsella may mitigate infection and exacerbation of COVID-19 by producing ursodeoxycholate
por: Hirayama, Masaaki, et al.
Publicado: (2021)

Subthalamic nucleus and globus pallidus interna influence firing of tonically active neurons in the primate striatum through different mechanisms
por: Nakajima, Asuka, et al.
Publicado: (2017)

Gut microbiota in dementia with Lewy bodies
por: Nishiwaki, Hiroshi, et al.
Publicado: (2022)

Ceruloplasmin in Parkinson's disease and the nonmotor symptoms
por: Zhao, Xuemei, et al.
Publicado: (2018)

Nonmotor symptoms in spinocerebellar ataxias (SCAs)
por: Moro, Adriana, et al.
Publicado: (2019)

Nonmotor Symptoms in Dystonia: Pathophysiological Implications
por: Mishra, Anumeha, et al.
Publicado: (2020)

Effects of Aging and Idiopathic Parkinson’s Disease on Tactile Temporal Order Judgment
por: Nishikawa, Natsuko, et al.
Publicado: (2015)

Dopamine-Induced Nonmotor Symptoms of Parkinson's Disease
por: Park, Ariane, et al.
Publicado: (2011)

Neuropathology and Neurochemistry of Nonmotor Symptoms in Parkinson's Disease
por: Ferrer, Isidro
Publicado: (2011)

Mindfulness for Motor and Nonmotor Dysfunctions in Parkinson's Disease
por: Dissanayaka, Nadeeka N. W., et al.
Publicado: (2016)

Evaluation of Nonmotor Symptoms in Diagnosis of Parkinsonism and Tremor
por: Evans, Andrew H., et al.
Publicado: (2016)

Characteristics of Nonmotor Symptoms in Progressive Supranuclear Palsy
por: Ou, Ruwei, et al.
Publicado: (2016)

The Risk Factors for the Wearing-off Phenomenon in Parkinson's Disease in Japan: A Cross-sectional, Multicenter Study
por: Ouma, Shinji, et al.
Publicado: (2017)

Safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease—Results of a multicenter open trial
por: Kashihara, Kenichi, et al.
Publicado: (2022)

Physical Activity and Its Diurnal Fluctuations Vary by Non-Motor Symptoms in Patients with Parkinson’s Disease: An Exploratory Study
por: Nagaki, Koichi, et al.
Publicado: (2022)

Validity of Single Tract Microelectrode Recording in Subthalamic Nucleus Stimulation
por: Umemura, Atsushi, et al.
Publicado: (2013)

Pilot feasibility study of a semi-automated three-dimensional scoring system for cervical dystonia
por: Nakamura, Takuto, et al.
Publicado: (2019)

Nonmotor Symptoms in a Malaysian Parkinson's Disease Population
por: Azmin, Shahrul, et al.
Publicado: (2014)

Effect of Exercise on Motor and Nonmotor Symptoms of Parkinson's Disease
por: Dashtipour, Khashayar, et al.
Publicado: (2015)

Update on Deep Brain Stimulation for Dyskinesia and Dystonia: A Literature Review
por: TODA, Hiroki, et al.
Publicado: (2016)

A Retrospective Imaging Evaluation of Presynaptic Dopaminergic Degeneration in Multiple System Atrophy with Levodopa Induced Dyskinesia
por: Ueno, Shin-ichi, et al.
Publicado: (2020)

Short chain fatty acids-producing and mucin-degrading intestinal bacteria predict the progression of early Parkinson’s disease
por: Nishiwaki, Hiroshi, et al.
Publicado: (2022)

Nonmotor Symptoms in Parkinson's Disease in 2012: Relevant Clinical Aspects
por: Bonnet, Anne Marie, et al.
Publicado: (2012)

Validation of the Korean-Version of the Nonmotor Symptoms Scale for Parkinson's Disease
por: Koh, Seong-Beom, et al.
Publicado: (2012)

Nonmotor Symptoms and Subthalamic Deep Brain Stimulation in Parkinson’s Disease
por: Kim, Han-Joon, et al.
Publicado: (2015)

Nonmotor gastrointestinal disorders in older patients with Parkinson’s disease: is there hope?
por: Georgescu, Doina, et al.
Publicado: (2016)

Sleep Related Problems as a Nonmotor Symptom of Dentatorubropallidoluysian Atrophy
por: Kim, Hyeyun, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_93lo37cis4fuuua83f8ifcslpu